Any adverse events relating to Baxter products should be reported to Baxter’s Pharmacovigilance team using the following contact details:
Phone: 01635 206360
Email: [email protected]
Ensuring patient safety is extremely important to us and we take the safety of all our medicines and devices very seriously.
Adverse Events may also be reported to the MHRA; reporting forms and information can be found at www.mhra.gov.uk/yellowcard
Important safety links
Information on the correct use of Baxter fibrin sealants with spray application: www.baxterspraysafety.com
Information on the use of glucose monitors in patients using Extraneal: www.glucosesafety.com/cont-eu.html